|
|
|
|
||
Re: Markets rip and BSGM dips. Why can't they turn their free placements into sales? ImoMabel You are correct about Kowalski. He spent 30 years in device sales focused on the EP Lab. Prior to joining BSGM he was 20 yrs as senior sales leader for JNJ Biosense Webster ( arguably the leader in EP). Nobody at Access Strategy has anywhere near the focused EP experience and industry contacts that Kowalski had. Access Strategy will quickly get feed back in the field that PureEp isn’t worth very much. If it were not for the testimonials of Dr Natalie and another few Drs this would have already died on the vine. The performance simply is marginal at best. The data culled from 2 clinical trials has been unimpressive. In fact , Julie Stephenson who ran those clinical trials and produced the data for BSGM is no longer with the company. The manufacturer has been replaced and they still have 50 devices in inventory that they can’t sell. Kowalski is gone and Stephenson is gone. All of a sudden a third party contract sales organization is going to sell this? I don’t think so. BSGM has 3 or 4 months of cash left. Robbie the pumper has disappeared and working behind the scenes with his consultant buddy Plum Creek pumping a few new names. . |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1711 | Re: CORRECTION!....Markets rip and BSGM dips. Why can't they turn their free placements into sales? Imo | Firstngoal | 0 | 12/23/2021 12:31:57 PM |